Multi-lineage Lung Regeneration by Stem Cell Transplantation across Major Genetic Barriers.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
21 01 2020
Historique:
received: 10 04 2019
revised: 24 09 2019
accepted: 16 12 2019
entrez: 23 1 2020
pubmed: 23 1 2020
medline: 18 3 2021
Statut: ppublish

Résumé

Induction of lung regeneration by transplantation of lung progenitor cells is a critical preclinical challenge. Recently, we demonstrated that robust lung regeneration can be achieved if the endogenous stem cell niches in the recipient's lung are vacated by sub-lethal pre-conditioning. However, overcoming MHC barriers is an additional requirement for clinical application of this attractive approach. We demonstrate here that durable tolerance toward mis-matched lung progenitors and their derivatives can be achieved without any chronic immune suppression, by virtue of co-transplantation with hematopoietic progenitors from the same donor. Initial proof of concept of this approach was attained by transplantation of fetal lung cells comprising both hematopoietic and non-hematopoietic progenitors. Furthermore, an even higher rate of blood and epithelial lung chimerism was attained by using adult lung cells supplemented with bone marrow hematopoietic progenitors. These results lay the foundation for repair of lung injury through a procedure akin to bone marrow transplantation.

Identifiants

pubmed: 31968255
pii: S2211-1247(19)31715-2
doi: 10.1016/j.celrep.2019.12.058
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

807-819.e4

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests U.S. Patent No. 9,833,482 related to this work was issued in 2017.

Auteurs

Carmit Hillel-Karniel (C)

Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.

Chava Rosen (C)

Department of Immunology, Weizmann Institute of Science, Rehovot, Israel; Department of Stem Cell Transplantation and Cell Therapy, MD Anderson Cancer Center, Houston, TX, USA; Department of Neonatology, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tal-Hashomer, Israel; The Talpiot Medical Leadership Program, Sheba Medical Center, Tel-Hashomer, Israel.

Irit Milman-Krentsis (I)

Department of Immunology, Weizmann Institute of Science, Rehovot, Israel; Department of Stem Cell Transplantation and Cell Therapy, MD Anderson Cancer Center, Houston, TX, USA.

Ran Orgad (R)

Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.

Esther Bachar-Lustig (E)

Department of Immunology, Weizmann Institute of Science, Rehovot, Israel; Department of Stem Cell Transplantation and Cell Therapy, MD Anderson Cancer Center, Houston, TX, USA.

Elias Shezen (E)

Department of Immunology, Weizmann Institute of Science, Rehovot, Israel; Department of Stem Cell Transplantation and Cell Therapy, MD Anderson Cancer Center, Houston, TX, USA.

Yair Reisner (Y)

Department of Immunology, Weizmann Institute of Science, Rehovot, Israel; Department of Stem Cell Transplantation and Cell Therapy, MD Anderson Cancer Center, Houston, TX, USA. Electronic address: yreisner@mdanderson.org.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH